Research Article

Outcome of Allogeneic Adult Stem Cell Therapy in Dogs Suffering from Osteoarthritis and Other Joint Defects

Table 2

Osteoarthritis grade evaluated by the vets prior to CAD-MSC treatment.

Age groupGrade 2Grade 3Grade 4

A: 0–5 years141414
B: 6–9 years15406
C: 10–13 years34216
D: 14–16 years0722